Filter
1466
Filtered Results: 1466
Text search:
Africa
CDC
Centers
for
Disease
Control
and
Prevention
Featured
Recommendations
190
New Publications
382
Language
Document type
No document type
771
Guidelines
206
Studies & Reports
187
Manuals
84
Fact sheets
79
Strategic & Response Plan
58
Training Material
30
Infographics
17
Brochures
15
Situation Updates
13
Resource Platforms
6
Countries / Regions
Africa
117
West and Central Africa
86
East and Southern Africa
65
Sierra Leone
64
Middle East and North Africa
64
Liberia
60
Nigeria
49
Ethiopia
47
Kenya
45
Global
42
Mozambique
36
Uganda
34
South Africa
33
Guinea
29
South Sudan
29
Tanzania
28
Rwanda
27
Zambia
26
Angola
26
Malawi
23
Yemen
23
Senegal
21
Guinea-Bissau
21
Ghana
20
Syria
20
Namibia
19
Congo, Democratic Republic of
18
Zimbabwe
16
India
11
Madagascar
11
Burkina Faso
10
Western and Central Europe
9
Côte d’Ivoire / Ivory Coast
8
Nepal
8
Botswana
8
Germany
7
Eswatini/ Swaziland
7
Lesotho
7
Mali
6
Cameroon
6
Bangladesh
6
Brazil
6
Latin America and the Carribbean
6
Asia
6
Eastern Europe
6
Ukraine
5
Russia
5
Vietnam
5
USA
4
Pakistan
4
Benin
4
Central African Republic
4
Saudi Arabia
3
Niger
3
Togo
3
Philippines
3
Somalia
3
Chad
3
Iraq
2
Afghanistan
2
Egypt
2
Gambia
2
China
2
Indonesia
2
Sudan
2
South–East Asia Region
2
Western Pacific Region
2
France
2
Tunisia
2
Portugal
2
Morocco
1
Haiti
1
Jordan
1
Lebanon
1
Turkey
1
Cambodia
1
Thailand
1
Malaysia
1
Burundi
1
Cape Verde
1
Paraguay
1
Venezuela
1
Djibouti
1
Southern Africa
1
Qatar
1
North America
1
Gabon
1
Japan
1
Mauritius
1
United Kingdom
1
Spain
1
South Korea
1
Morocco
1
Authors & Publishers
Publication Years
Category
Countries
599
Clinical Guidelines
123
Public Health
72
Key Resources
66
Women & Child Health
48
Capacity Building
27
Pharmacy & Technologies
25
Toolboxes
COVID-19
303
HIV
147
Ebola
134
Rapid Response
99
TB
99
AMR
60
Zika
29
Mental Health
29
Planetary Health
24
NTDs
20
Caregiver
18
NCDs
18
Polio
14
Refugee
13
Cholera
12
Pharmacy
12
Global Health Education
10
Health Financing Toolbox
10
Disability
7
Specific Hazards
5
Conflict
4
Natural Hazards
4
Social Ethics
1
Ivermectin is an antiparasitic drug approved for the treatment of parasitic infections, including strongyloidiasis and onchocerciasis in humans. There is a reported increase in the use of ivermectin...
24 Nov. 2021; This guidance provides considerations and a series of options that can be used to inform country strategies to minimise risk associated with shortages of personal protective equipment (PPE).
Re-use ... reprocessing of single use PPE must be a last-resort temporary measure that is implemented only until stocks are replenished (2).This remains an area of active research and further updates to this evidence base are anticipated.
This guidance will assist staff, students and caregivers in schools (including day care centres, pre-school, primary and secondary schools), higher...
March 2020
This document provides a high-level mapping of outbreak stages with guidance on how to time the minimum uptake of different interventions that have been recommended by Africa CDC, driven...
This document provides guidance to AU Member States, states/local bodies, and communities
on how to construct and maintain non-contact hand washing stations like Tippy Taps ... other
alternative hand washing stations.
Strategies for managing acute shortages of personal protective equipment during COVID-19 pandemic
recommended
This guidance provides considerations and a series of options that can be used to inform country strategies in managing any shortages of personal protective equipment.Re-use and reprocessing of sing...
The global pandemic has highlighted fragility in international supply chains and the dependency of many African countries on imported personal protective equipment (PPE). Market pressures have also increased prices ... imported supplies and put additional pressure on areas with limited resources for procurement. There is an urgent operational need to develop the domestic capacity to supply PPE from within the African continent. There is huge variation in Member
States industrial manufacturing capacity and the regulatory and testing capacity of government agencies at present. Growing number of companies, including micro- and small-medium enterprises, have responded by repurposing, albeit temporarily, to manufacture an assortment of PPEs. This workshop aims to bring together government representatives, industry, and subject matter experts on material testing and standards to promote the development of domestic production of safe and effective PPE made in Africa.
The strategy recommends that AU Member States should enhance, where feasible, existing COVID-19 surveillance to include:
Community-based surveillance to detect symptomatic cases early for treatment ... to avert viral transmission;
Sentinel surveillance in high-risk populations to detect and track both presymptomatic and asymptomatic cases; and
Wastewater surveillance to monitor early environmental signs of virus transmission and identify communities where targeted interventions can be implemented to decrease transmission.
Quality Assurance Framework for SARS-CoV-2 Antigen Rapid Testing for Diagnosis of COVID-19
recommended
ASLM in collaboration with the Africa Centres for Disease ... and Prevention, and in partnership with the Clinton Health Access Initiative, Amref and Last Mile Health present the Quality Assurance Framework for SARS-CoV-2 Antigen Rapid Testing for Diagnosis of COVID-19. This framework aims to provide general technical guidance to African Union Members States on the rollout, establishment, implementation, monitoring, and evaluation of SARS-CoV-2 Ag RDT interventions so as to effectively and efficiently detect, control and minimise errors in the performance of COVID-19 laboratory testing processes. It describes the core components for quality assurance, resources mobilisation and advocacy for scale up, monitoring, evaluation, learning and accountability for SARS-CoV-2 implementation.
According to the World Health Organization (WHO), sub-Saharan Africa has only 3% of the world’s health workers to cater for 11% of the world population, bearing over 25% of the global ... burden (WHO, 2014). With a steady increase in reported cases on the African Continent, the current COVID-19 pandemic threatens to overwhelm our already taxed health infrastructure. It is, therefore, imperative to take serious and urgent measures towards disease management and monitoring especially as the need for self-quarantine and contact surveillance rises.
In view of the infrastructural and resource gaps, technology should be considered for remote management of healthcare deliver to patients during this period. As it is abundantly clear, even countries with more advanced healthcare infrastructure and resources have struggled to treat COVID-19 and non-COVID-19 patients during this pandemic.
Biosafety involves the implementation of containment principles, technologies and practices to prevent unintentional exposure to biological agents. Biosecurity involves the protection, control ... accountability of biological materials and information related to these materials and dualuse research, to prevent their unauthorized access, loss, theft, misuse, diversion or intentional release.
17 Febr. 2022. As part of the “Strategy to Achieve Global COVID-19 Vaccination by mid-2022”, global targets of 40% population coverage by end of 2021 and 70% coverage by June 2022 have been set by the World Health Organization (WHO), to successf...
In 2007, WHO warned that infectious diseases are emerging and re-emerging at a rate that has not been seen before. The potential for infectious ... to spread rapidly results in high morbidity and mortality, causing a potential global public health treat of major concern.
Several factors are contributing to the (re)emergence of infectious diseases such as population growth, living in close contact with animals, frequent travelling, poverty, destructive ecological changes due to economic development and land use and climate change result in global warming.
Especially Africa is at a threat for (re)emerging infectious diseases due to the huge population growth (expected to reach 2.5 billion by 2050) with rapid urbanisation. Additionally, people across and beyond the continent are excessively mobile which is combined with a weak health system. Moreover, the risk of (re)emerging infectious disease is further heightened by three newly adopted continental initiatives: African Continental Free Trade Area, Free Movement of Persons and African Passport and Single African Air Transport Market.
إن حول الإصدارات الإعلامية للنتائج الأولية للتجربة الإكلينيكية العشوائية ٍّتام) والتي تضمنت ديكساميثازون على إدراك Africa ... المركز الأفريقي لمكافحة الأمراض و الوقاية منها، UKالكبيرة التي أجريت في المملكة المتحدة () أفاد الباحثون بأن إعطاء ديكساميثازون ۱وكورتيكوستيرويد كإحدى أذرع العلاج.(عن طريق الفم أو عن طريق الحقن أدى إلى انخفاض حوالي ثلث الوفيات بين الذين يحتاجون إلى i]COVID-19المرضى المصابين بفيروس كورونا المستجد [َّتهوية ميكانيكية وحوالي الخمس للمرضى الذين يحتاجون إلى الأكسجين. إنا مدرج في قائمة الأدوية الأساسية ًديكساميثازون هو دواء عام وغير مكلف نسبيإفريقيا.لمنظمة الصحة العالمية ويستخدم على نطاق واسع في
الاستراتيجيات لإدارة النقص الحاد في معدات الحماية الشخصية خلال جائحة فيروس COVID-19
This guidance provides considerations and a series of options that can be used to inform country str...
إرشاداتٌ حول إنشاء عنابر العزل الخاصة بالحالات المصابة بفيروس كورونا المستجد
This document simplifies the WHO guidance on severe acute respiratory infection (SARI) treatment centres...
